Physician profile
Sameeha Khalid
NPI 1114489705
$1,944.04
in general payments reported to CMS, 2019-2025
17 companies · $1,327 in 2025
The $1,327 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $617 · 2025: $1,327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,859 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,859.05 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $403.87 | 2024-2025 | Tremfya, Stelara |
| Ipsen Biopharmaceuticals, INC | $314.10 | 2025 | Iqirvo |
| Abbvie INC. | $276.33 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $206.71 | 2024-2025 | Dupixent |
| Lilly USA, LLC | $197.37 | 2024-2025 | Omvoh, Zepbound |
| Madrigal Pharmaceuticals | $164.19 | 2024-2025 | Rezdiffra, Resmetirom |
| Tempus Ai, INC | $115.29 | 2025 | Xt Cdx |
| Gilead Sciences, INC. | $66.72 | 2024 | |
| Caris Mpi, INC. | $31.21 | 2025 | Mi Cancer Seek |
| Abbott Laboratories | $27.04 | 2025 | Freestyle Libre 3 |
| Genzyme Corporation | $26.68 | 2025 | |
| Boston Scientific Corporation | $22.59 | 2024 | |
| Celltrion USA INC. | $21.53 | 2025 | Vegzelma |
| Ardelyx, INC. | $20.19 | 2024 | Ibsrela |
| Urgo Medical North America, LLC | $18.03 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $16.71 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Phathom Pharmaceuticals, INC. | $15.48 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameeha Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.